GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Example 161 [WO2011153942A1]
Compound class:
Synthetic organic
Comment: We obtained the chemical structure for sacibertinib from the WHO's proposed INN list 127 (21 July 2022). In this document it was described as a tyrosine kinase inhibitor and antineoplastic. This same chemical structure is claimed in patent WO2011153942A1 [1]. Inventions of this patent are described as inhibitors of erbB family receptor tyrosine kinases, in particular of EGFR and Her2 (ERBB2).
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| (E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3S)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 12300 | sacibertinib |
Synonyms ![]() |
| Example 161 [WO2011153942A1] |
Database Links ![]() |
|
| CAS Registry No. | 1351941-69-9 (source: WHO INN record) |
| GtoPdb PubChem SID | 472319212 |
| PubChem CID | 89496273 |
| Search Google for chemical match using the InChIKey | ZGYIXVSQHOKQRZ-COIATFDQSA-N |
| Search Google for chemicals with the same backbone | ZGYIXVSQHOKQRZ |
| Search PubMed clinical trials | sacibertinib |
| Search PubMed titles | sacibertinib |
| Search PubMed titles/abstracts | sacibertinib |
| UniChem Compound Search for chemical match using the InChIKey | ZGYIXVSQHOKQRZ-COIATFDQSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | ZGYIXVSQHOKQRZ-COIATFDQSA-N |